Assay Detail
Binding
CHEMBL4266244
Review assay metadata, readout intent, target linkage, and publication context from the same page.
Inhibition of wild type ROS1 (unknown origin)
5
Total Activities
5
Compounds Tested
1
Activity Types
0
Assay Parameters
Assay Information
| Assay Type | Binding |
| Organism | Homo sapiens |
| Confidence | 9 — Direct single protein target |
| Curated By | Autocuration |
Target
Proto-oncogene tyrosine-protein kinase ROS (CHEMBL5568) ↗| Type | SINGLE PROTEIN |
| Organism | Homo sapiens |
Publication
First macrocyclic 3rd-generation ALK inhibitor for treatment of ALK/ROS1 cancer: Clinical and designing strategy update of lorlatinib.
Activity Statistics
| Type | Count | Avg pChEMBL | Best pChEMBL |
|---|---|---|---|
| Ki | 5 | 8.02 | 9.22 |
Compounds Tested
| Compound | Name | Phase | Activities | Best pChEMBL |
|---|---|---|---|---|
| CHEMBL601719 | CRIZOTINIB | 4.0 | 1 | 9.22 |
| CHEMBL2403108 | CERITINIB | 4.0 | 1 | 9.15 |
| CHEMBL1230609 | FORETINIB | 2.0 | 1 | 8.09 |
| CHEMBL1738797 | ALECTINIB | 4.0 | 1 | 5.62 |
| CHEMBL3286830 | LORLATINIB | 4.0 | 1 | - |
Activity Data
| Compound | Name | Type | Rel. | Value | Units | pChEMBL |
|---|---|---|---|---|---|---|
| CHEMBL601719 | CRIZOTINIB | Ki | = | 0.6 | nM | 9.22 |
| CHEMBL2403108 | CERITINIB | Ki | = | 0.7 | nM | 9.15 |
| CHEMBL1230609 | FORETINIB | Ki | = | 8.2 | nM | 8.09 |
| CHEMBL1738797 | ALECTINIB | Ki | = | 2400.0 | nM | 5.62 |
| CHEMBL3286830 | LORLATINIB | Ki | < | 0.025 | nM | - |